Milk announced an acquisition and a divestiture as it aims to take a bigger slice of China’s baby formula market.

We expect revenue growth to moderate as Cochlear implant sales to children slow down and average selling prices decline, ...

There are some obvious red flags that investors intuitively know to steer clear of – high fees, low liquidity, poor ...

The problem for Buffett is that he would know that time is ticking to deploy his cash. He’s stepping down as CEO at the end ...

Telstra’s ( ASX: TLS) fiscal 2025 underlying earnings before interest, taxes, depreciation and amortisation (“EBITDA”) grew ...

But instead of falling for hype, fund investors should try to remain focused on their long-term goals. Broad based equity ...

Pro Medicus’ ( ASX: PME) fiscal 2025 earnings before interest and taxs (“EBIT”) grew 40%, with revenue up 32% on contract ...

The saying ‘nothing ever happens’ is a product of strong share market returns and bear markets that end before anyone notices ...

This is the first of three ASX reporting season wraps being sent in August and early September. This edition includes a ...

Despite a 40% share price rally this year, investors could still be underestimating Alibaba’s cloud growth prospects.

REA Group shares now screen as wildly overvalued, as the market seems to expect price hikes to continue for much longer than ...

Westpac’s (ASX: WBC) third-quarter 2025 underlying profit of AUD 1.9 billion increased 8% on the first half of fiscal 2025 ...